While medtech’s performance still isn’t mirroring the beginning of 2021, the industry is showing signs of life with a small improvement last week. The year’s strong start, during which MassDevice‘s MedTech 100 index notched an all-time best of 110.96 points (Feb. 15) came to an end later that month and carried over into March, with the […]
Decision Diagnostics
Investors sue Decision Diagnostics over COVID-19 test
Decision Diagnostics is facing legal action after the company allegedly misled investors about developing a COVID-19 diagnostic. Licgo Partners, Sovereign Partners and Paradigm Capital, all investor companies, sued Decision Diagnostics and CEO Keith Berman in federal court under allegations that Berman had falsely stated that the company was developing an at-home COVID-19 test that was […]
SEC charges diagnostics company with fraud over COVID-19 test claims
The SEC announced charges against Decision Diagnostics (OTCMKTS:DECN) and its CEO, alleging false and misleading claims over a COVID-19 blood test. Westlake Village, Calif.-based Decision Diagnostics and its CEO Keith Berman are alleged to have made the claims in numerous press releases, saying that the company had developed a working, breakthrough technology for detecting COVID-19 […]
Decision Diagnostics sues J&J’s LifeScan over glucose test strip patents
Decision Diagnostics (OTC:DECN) said today its subsidiaries Decision IT and Pharma Tech Solutions filed a lawsuit against Johnson & Johnson (NYSE:JNJ) and its Lifescan divisions over patent infringement related to glucose testing strips, looking for compensation between $400 and $700 million. The Los Angeles-based company said the patent infringement case centers around 3 features and 2 […]
Decision Dx wins test strip patent challenge to J&J’s LifeScan
A federal appeals court yesterday upheld a U.S. Patent & Trademark Office decision that a blood glucose testing patent owned by JNJ subisidary LifeScan is invalid. The U.S. Court of Appeals for the Federal Circuit’s per curiam decision, issued without comment, was a win for Decision Diagnostics (OTC:DECN) subsidiary PharmaTech Solutions and its GenStrip 50 test strip. […]
Diabetes: J&J loses a round in glucose testing battle with Shasta
